Health Catalyst, AppLovin, PubMatic, and Pegasystems Shares Rise, Key Information to Consider

Market Activity Overview

Several stocks experienced notable gains during the afternoon as a broad-based rally signaled renewed enthusiasm among investors for this sector.

This surge was part of a larger movement, with the main software ETF (IGV) outperforming the NASDAQ by 9% over the previous week. The upswing followed a stretch where software equities had trailed the broader market. Morgan Stanley analysts observed that investor attention was shifting away from general AI hype and toward software firms delivering secure, practical solutions for businesses. Their research indicated that enterprise adoption of AI is now focused on specific applications, such as software engineering and data retrieval, reflecting a more advanced stage of investment in the field.

Stock prices often react strongly to news, and significant declines can create opportunities to purchase quality companies at attractive prices.

The following stocks were among those affected:

• Health Catalyst (NASDAQ:HCAT), a data analytics provider, soared by 12.4%.

• AppLovin (NASDAQ:APP), specializing in advertising software, climbed 9%.

• PubMatic (NASDAQ:PUBM), another advertising software company, advanced 5.4%.

• Pegasystems (NASDAQ:PEGA), which focuses on automation software, rose 5.9%.

Spotlight on Health Catalyst (HCAT)

Health Catalyst’s stock is known for its volatility, having experienced over 50 swings greater than 5% in the past year. However, the recent surge stands out even by its standards, suggesting the news had a significant effect on how the market views the company.

The last major movement occurred two days ago, when Health Catalyst’s shares jumped 6.2% after software stocks rebounded as investors looked past rising uncertainty amid Middle East tensions. The previous downturn, dubbed the "SaaSpocalypse," was fueled by concerns that new AI technologies could disrupt the business models of enterprise software firms. The latest rally indicates that investors are moving from panic to a more discerning approach, seeking out potential "AI Winners."

Since the start of the year, Health Catalyst has dropped 14.3%. Currently trading at $1.96 per share, it sits 57.5% below its 52-week high of $4.60 reached in March 2025. For context, a $1,000 investment in Health Catalyst five years ago would now be valued at just $41.62.

Additional Insight

Don’t Miss This: The $21 AI Application Stock Overlooked by Wall Street. While much of Wall Street is focused on AI developers, one company is already leveraging AI to generate significant profits—and it’s flying under the radar.

AI chip stocks are trading at sky-high multiples, but this business, which processes a trillion consumer signals each month using AI, is available at just a third of the price. This discrepancy is unlikely to last as institutional investors catch on. Be among the first to learn more.